Literature DB >> 10206996

Neurite outgrowth in PC12 cells. Distinguishing the roles of ubiquitylation and ubiquitin-dependent proteolysis.

M Obin1, E Mesco, X Gong, A L Haas, J Joseph, A Taylor.   

Abstract

Nerve growth factor (NGF)-induced neurite outgrowth from rat PC12 cells was coincident with elevated (>/=2-fold) levels of endogenous ubiquitin (Ub) protein conjugates, elevated rates of formation of 125I-labeled Ub approximately E1 (Ub-activating enzyme) thiol esters and 125I-labeled Ub approximately E2 (Ub carrier protein) thiol esters in vitro, and enhanced capacity to synthesize 125I-labeled Ub-protein conjugates de novo. Activities of at least four E2s were increased in NGF-treated cells, including E2(14K), a component of the N-end rule pathway. Ubiquitylation of 125 I-labeled beta-lactoglobulin was up to 4-fold greater in supernatants from NGF-treated cells versus untreated cells and was selectively inhibited by the dipeptide Leu-Ala, an inhibitor of Ub isopeptide ligase (E3). However, Ub-dependent proteolysis of 125I-labeled beta-lactoglobulin was not increased in supernatants from NGF-treated cells, suggesting that neurite outgrowth is promoted by enhanced rates of synthesis (rather than degradation) of Ub-protein conjugates. Consistent with this observation, neurite outgrowth was induced by proteasome inhibitors (lactacystin and clasto-lactacystin beta-lactone) and was associated with elevated levels of ubiquitylated protein and stabilization of the Ub-dependent substrate, p53. Lactacystin-induced neurite outgrowth was blocked by the dipeptide Leu-Ala (2 mM) but not by His-Ala. These data 1) demonstrate that the enhanced pool of ubiquitylated protein observed during neuritogenesis in PC12 cells reflects coordinated up-regulation of Ub-conjugating activity, 2) suggest that Ub-dependent proteolysis is a negative regulator of neurite outgrowth in vitro, and 3) support a role for E2(14K)/E3-mediated protein ubiquitylation in PC12 cell neurite outgrowth.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10206996     DOI: 10.1074/jbc.274.17.11789

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death.

Authors:  L Stefanis; K E Larsen; H J Rideout; D Sulzer; L A Greene
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

Review 2.  Roles for the ubiquitin-proteasome pathway in protein quality control and signaling in the retina: implications in the pathogenesis of age-related macular degeneration.

Authors:  Fu Shang; Allen Taylor
Journal:  Mol Aspects Med       Date:  2012-04-10

3.  Proteasome inhibition by fellutamide B induces nerve growth factor synthesis.

Authors:  John Hines; Michael Groll; Margaret Fahnestock; Craig M Crews
Journal:  Chem Biol       Date:  2008-05

Review 4.  Role of the ubiquitin-proteasome system in nervous system function and disease: using C. elegans as a dissecting tool.

Authors:  Márcio S Baptista; Carlos B Duarte; Patrícia Maciel
Journal:  Cell Mol Life Sci       Date:  2012-03-03       Impact factor: 9.261

5.  Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments.

Authors:  Xiang Li; Chuan-En Wang; Shanshan Huang; Xingshun Xu; Xiao-Jiang Li; He Li; Shihua Li
Journal:  Hum Mol Genet       Date:  2010-03-30       Impact factor: 6.150

6.  Construction and analysis of mouse strains lacking the ubiquitin ligase UBR1 (E3alpha) of the N-end rule pathway.

Authors:  Y T Kwon; Z Xia; I V Davydov; S H Lecker; A Varshavsky
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

7.  A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons.

Authors:  Takafumi Tasaki; Lubbertus C F Mulder; Akihiro Iwamatsu; Min Jae Lee; Ilia V Davydov; Alexander Varshavsky; Mark Muesing; Yong Tae Kwon
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 8.  The role of the ubiquitin proteasome system in ischemia and ischemic tolerance.

Authors:  Robert Meller
Journal:  Neuroscientist       Date:  2009-01-30       Impact factor: 7.519

9.  Posttranslational protein knockdown coupled to receptor tyrosine kinase activation with phosphoPROTACs.

Authors:  John Hines; Jonathan D Gough; Timothy W Corson; Craig M Crews
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-14       Impact factor: 11.205

10.  Systemic administration of proteasome inhibitor protects against MPTP neurotoxicity in mice.

Authors:  Takuya Oshikawa; Hayato Kuroiwa; Ryohei Yano; Hironori Yokoyama; Naoto Kadoguchi; Hiroyuki Kato; Tsutomu Araki
Journal:  Cell Mol Neurobiol       Date:  2009-04-16       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.